Fifteen years
after the International Olympic Committee (IOC) introduced a test for the
detection of erythropoietin (EPO) India has opened its account for an
anti-doping rule violation for the red-blood-cell boosting drug.
Distance runner
Hari Shankar Sharma, who tested positive for EPO at the All-India Police
athletics championships at Madhuban, Haryana, in November last year, has been
suspended for two years by the National Anti-Doping Disciplinary Panel (NADDP).
That this case,
dating back to 28 November, 2014 could be decided only on 5 November, 2015 was
due to a combination of reasons.
The New Delhi
Dope Testing Laboratory (NDTL), a WADA-accredited laboratory, is shown to have
tested the ‘A’ urine sample on 10 March, 2015. But apparently confirmatory evaluation was by then done by another WADA-accredited laboratory in Seibersdorf,
Austria and that explained the first delay. The Austrian laboratory is the
Athlete Passport Management Unit (APMU) for tests done by the National
Anti-Doping Agency (NADA).
Delays
By the time the ‘B’
sample test was done and presence of EPO confirmed it was May. There was a further
time lag since the hearing panels had ended their term in February this year
and were not reconstituted by the Government till July. Actually the old panels were re-nominated then
and a further reconstitution done only last month. Sharma’s case got delayed in
the backlog and was taken up on 20 October.
Sharma did not
put up a credible defence, going by the order issued by a panel headed by Mr.
Ramnath and including international shooter Moraad Ali Khan and DrL. K. Gupta.
The Rajasthan runner who took the gold in the 10,000 metres (30:07.48, ranked 7th in India in 2014) and the silver in
the 5000 metres (14:35.38, ranked 12th) at Madhuban, argued that he had undergone treatment for an
elbow injury in 2014 and was prescribed some medicines. There was no
prescription to back up that claim. He also said he had consumed calcium and
vitamin tablets.
Sharma was lucky
that his case came under the old Code (2009) and not 2015 since the minimum
sanction under the new rules would have been for four years unless
unintentional ingestion was established.
What is EPO?
EPO is a hormone
produced by the kidneys. An increase in EPO will mean extra red blood cells
which in turn will mean supply of more oxygen to the muscles. Artificially it
is prepared through recombinant DNA technology. It is used to treat anaemia in
the medical field but it also happens to be favourite among endurance athletes
for doping purposes. The Tour de France has been notorious for EPO misuse. American
Lance Armstrong, stripped of his seven Tour de France titles for doping and
banned for life, admitted that he had benefited from the use of EPO.
Just as
Armstrong pointed out in the documentary the ‘Armstrong Lie’, EPO detection is
difficult since its half life (period during which it could be detected in
blood) is around four to five hours. Initially the IOC accepted a method of
blood test and urine test to confirm EPO ‘positive’ just in time for the Sydney
Olympics. Not many were caught in the initial years.
Subsequently, as
science and detection methods evolved, the World Anti Doping Agency (WADA) was
able to approve a stand-alone urine test, though it is costly to conduct. Many
anti-doping agencies including international federations even now use a
combination of blood and urine tests; many use blood tests for screening
purposes.
By 2008 the dopers were onto CERA (Continuous
Erythropoiesis Receptor Activator), a new form of EPO that was used to
help dialysis patients or people with kidney problems.
Biological Passport
Since 2009, WADA
has introduced the Athlete Biological Passport (ABP) programme by which an
athlete’s blood sample is tested and variables recorded during different stages
in order to assess misuse of erythropoiesis stimulating agents (ESA). Suspect
cases are followed up for target testing or else brought up as an anti-doping
rule violation charge if sufficient evidence is gathered.
The recent
uproar over ‘leaked data’ published by German TV ADR in collaboration with the
Sunday Times of U. K. related to EPO misuse and blood doping by elite athletes including
medal winners in Olympics and World Championships from several countries, Russia
topping that list.
The
International Association of Athletics Federations (IAAF) is still looking into
that issue while a second report by WADA Independent Commission that could be
expected to deal with the blood doping allegation among others could be out by
December-January.
Recent studies
have shown that micro-dosing in EPO is extremely difficult to catch. Athletes
can continue to dope and not get detected through micro-dosing, a BBC journalist proved
The NADA is yet
to begin haematological ABP programme though blood samples from India are taken
and international agencies could be expected to keep a watch on the data
generated over a period of time in order to carry out target testing at least.
NADA has however
started steroidal ABP (urine sample) by which an athlete’s steroidal pattern is
kept track of. WADA started the ABP (blood) programme in 2009 and the steroidal
module in January 2014.
EPO is costly.
Its testing is costlier than routine testing of urine samples, making agencies do tests only on a very limited number of
samples for the drug. EPO is available in the Indian market. How athletes, cyclists
etc could be misusing it in India could be assessed better once the ABP
programme is set in motion.
Quite
interestingly, a second EPO ‘positive’ reported in India in 2014 also came from
the Police championships at Madhuban. It is another distance runner who ran
alongside Sharma. His case is expected to be completed soon.
Just because
only two athletes have been caught so far in India for EPO should not mean
others were not using it. The detection window being small the others might
have been lucky to escape. We should
also remember that NADA came into being only in 2009 and the New Delhi
laboratory was accredited less than a year earlier. The ‘passport’ as and when
introduced should nail many EPO users in future.
Meanwhile, K. M.
Rachna, hammer thrower from UP, who stood second in the National Games in
Kerala last February, has been suspended for four years by the NADDP. She was
one of the 16 to have tested positive at the games. Rachna had tested positive
for steroid metenolone.
(amended 27 Nov 2015)
(amended 27 Nov 2015)